Lipocine Inc. (LPCN)
NASDAQ: LPCN · Real-Time Price · USD
6.57
+0.28 (4.45%)
Dec 30, 2025, 4:00 PM EST - Market closed
Lipocine Market Cap
Lipocine has a market cap or net worth of $36.48 million as of December 31, 2025. Its market cap has increased by 29.81% in one year.
Market Cap
36.48M
Enterprise Value
21.50M
1-Year Change
29.81%
Ranking
Category
Stock Price
$6.57
Market Cap Chart
Since March 21, 2014, Lipocine's market cap has decreased from $82.30M to $36.48M, a decrease of -55.68%. That is a compound annual growth rate of -6.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 36.50M | 39.85% |
| Dec 31, 2024 | 26.10M | 76.35% |
| Dec 29, 2023 | 14.80M | -57.95% |
| Dec 30, 2022 | 35.20M | -59.77% |
| Dec 31, 2021 | 87.50M | -2.02% |
| Dec 31, 2020 | 89.30M | 811.22% |
| Dec 31, 2019 | 9.80M | -64.87% |
| Dec 31, 2018 | 27.90M | -61.73% |
| Dec 29, 2017 | 72.90M | 8.48% |
| Dec 30, 2016 | 67.20M | -71.53% |
| Dec 31, 2015 | 236.00M | 250.67% |
| Dec 31, 2014 | 67.30M | -18.23% |
| Mar 21, 2014 | 82.30M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 965.55B |
| Johnson & Johnson | 499.23B |
| AbbVie | 404.55B |
| UnitedHealth Group | 300.58B |
| AstraZeneca | 287.56B |
| Novartis AG | 266.91B |
| Merck & Co. | 263.37B |
| Novo Nordisk | 227.80B |